Bristol Myers Squibb (BMY) Current Deferred Tax Assets (2009 - 2015)

Bristol Myers Squibb (BMY) has reported Current Deferred Tax Assets for 7 consecutive years, with $1.7 billion the latest figure, recorded in Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 14.64% year-over-year to $1.7 billion in Q3 2015; TTM through Sep 2015 was $1.7 billion, a 14.64% increase from a year earlier, with the FY2014 full-year figure at $1.6 billion, down 3.35% from the prior year.
• Current Deferred Tax Assets was $1.7 billion for Q3 2015 at Bristol Myers Squibb, down from $1.9 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $2.0 billion in Q3 2013 and troughed at $1.1 billion in Q2 2011.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2014 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets soared 66.81% in 2013 and tumbled 30.82% in 2014, its largest moves.
• Over 5 years, Current Deferred Tax Assets stood at $1.2 billion in 2011, then jumped by 33.08% to $1.6 billion in 2012, then increased by 6.51% to $1.7 billion in 2013, then retreated by 3.35% to $1.6 billion in 2014, then increased by 5.29% to $1.7 billion in 2015.
• The last three Current Deferred Tax Assets figures came in at $1.7 billion (Q3 2015), $1.9 billion (Q2 2015), and $1.9 billion (Q1 2015), per Business Quant data.